Chronic pelvic pain syndrome
ICD-10 R10.2 ICD-11 MG30.00

Treatment of Chronic Pelvic Pain Syndrome in Male Patients with Urinary Voiding Symptoms

This protocol addresses chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) specifically in male patients who also present with urinary voiding symptoms — a defined clinical subpopulation for which guideline evidence supports a targeted first-line approach.

Clinical Scenario

Male patients with CP/CPPS who experience concurrent urinary voiding symptoms represent a distinct presentation. Guideline recommendations specifically address this combination, and the evidence base for this subgroup is well-established.

Treatment Goals

The protocol targets measurable improvement across all NIH-CPSI domains: overall total score, urinary symptoms subscore, pain subscore, and quality-of-life subscore.

Approach

For male CP/CPPS patients with voiding symptoms, guideline evidence supports offering a specific class of pharmacological agents. The full protocol specifies which agents within that class apply, how to select among them, and which outcome parameters to monitor.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1097/JU.0000000000004564

In patients with CP/CPPS and voiding symptoms, clinicians should offer treatment with an alpha-blocker.

Alpha-blockers were also associated with improvement versus placebo on each NIH-CPSI subscores (pain: 13 trials; n=1,243; urinary symptoms: 13 trials; n=1,243; and QOL: 13 trials; n=1,243).

View source ↗